Antacids linked to reduced erlotinib efficacy By Laura Cowen here.
Antacids linked to reduced erlotinib efficacy By Laura Cowen, medwireNews Reporter Acid suppression therapy might negatively impact outcome among patients receiving erlotinib for advanced non-small-cell lung cancers , Canadian research findings show. Related StoriesViralytics enters into clinical trial collaboration agreement with MSDMeat-rich diet may increase kidney cancers riskFDA grants accelerated authorization for Tagrisso to treat individuals with advanced NSCLCTo investigate whether this impacts clinical outcome, Sawyer and colleaguesreviewed data for 507 advanced NSCLC individuals receiving erlotinib from 2007 to 2012 at a big, centralised cancer institution in Canada. 25 percent of these sufferers received concomitant AS, most commonly with a PPI , and the researchers note that there have been no statistically significant differences in NSCLC baseline characteristics or Charlson comorbidity index between the AS and nonas groupings here .
Guayule is usually a commercial crop and the just rubber-producing species other than the Brazilian rubber tree that is used for latex production on a commercial scale. ‘Our collaboration will advance the acceptance of guayule organic rubber as a U.S. Biobased alternative for organic rubber and petroleum-structured rubber products.’.. Ansell purchases minority share of Yulex Ansell Small , a worldwide leader in protection solutions, today announced it provides purchased a minority share of Yulex Corporation, a manufacturer of biopolymers produced from guayule. Further, Yulex and Ansell executed an exclusive agreement for the global development, manufacturing and distribution privileges for medical gloves, personal protective products gloves, and condoms made of guayule latex.